Virginia VABK Q1 2026 In Line Whats Next for Investors XOMA XOMAP Rallies 104 as Bulls Target 2682 20260520 RenovoRx RNXT Q1 2026 Results Miss Estimates EPS 009 vs 008 Impact BioMedical IBO Rallies 269 as Bulls Target 057 20260520 Silicon Laboratories SLAB Steady at 21689 Awaiting Next Catalyst 20260520 HS2 Completion Delayed to 2039 Full Line Still Possible Despite Setbacks